Table 2. Comparison of outcome measures between and within ErCG and CG at both baseline and week 8.
| Outcome measure | ErCG (Mean ± SD) | CG (Mean ± SD) | |
|---|---|---|---|
| FAC | |||
| Baseline | 2.8 ± 0.6 | 2.9 ± 0.7 | |
| Week 8 | 4.0 ± 0.8# | 3.1 ± 1.3 | |
| AV (m/s) | |||
| Baseline | 0.64 ± 0.18* | 0.46 ± 0.22 | |
| Week 8 | 0.74 ± 0.18#* | 0.49 ± 0.24 | |
| 6-MWT (m) | |||
| Baseline | 278.7 ± 58.06 | 251.7 ± 56.1 | |
| Week 8 | 310.6 ± 63.9#* | 268.5 ± 55.1 | |
| HR (bpm) | |||
| Baseline | 75.0 ± 9.1 | 81.2 ± 4.0 | |
| Week 8 | 72.3 ± 6.3* | 79.3 ± 1.9 | |
| SBP (mmHg) | |||
| Baseline | 133.9 ± 12.2 | 134.0 ± 8.1 | |
| Week 8 | 123.0 ± 7.4#* | 133.1 ± 8.3 | |
| DBP (mmHg) | |||
| Baseline | 82.0 ± 7.2 | 83.6 ± 7.5 | |
| Week 8 | 73.2 ± 9.0#* | 81.8 ± 8.7 | |
ErCG: ergometer cycling group; CG: control group; FAC: functional ambulatory category; AV: ambulatory velocity; 6-MWT: 6-Minute Walk Test; HR: heart rate; bpm: beats per minute; SBP: systolic blood pressure; DBP: diastolic blood pressure; mmHg: millimetres of Mercury; Mean ± SD: mean plus or minus standard deviation. *significant differences in outcome measures between ErCG and CG at both baseline and week 8. #significant differences in outcome measures from baseline to week 8 in ErCG.